XML 30 R19.htm IDEA: XBRL DOCUMENT v3.23.3
Share based compensation expenses
9 Months Ended
Sep. 30, 2023
Retirement Benefits [Abstract]  
Share based compensation expenses

12. Share based compensation expenses

Stock-based compensation expense is allocated based on (i) the cost center to which the award holder belongs, for employees, and (ii) the service rendered to the Company, for third-party consultants. The following table summarizes total stock-based compensation expense by account for the three and nine months ended September 30, 2023 and 2022.

                 
   Three Months Ended September 30,   Nine Months Ended September 30, 
   2023   2022   2023   2022 
Cost of revenue   (3)   2    0    14 
Research and development   7    35    31    133 
Sales and marketing   6    110    31    281 
SEPA financial expenses               186       
General and administrative   (47)   610    348    2,277 
Total Share based compensation expenses, net   (37)   757    596    2,705 
Of which related to shares not issued for services   rendered during the period, accrued as Account payables   233    34    251    34 

2023 Omnibus Incentive Plan

The Company adopted the 2023 Omnibus Incentive Plan (the “2023 Plan”) under which the Company may issue equity incentives to selected employees, officers, and director of the Company. The 2023 Plan permits the grant of Incentive Stock Options, Non-statutory Stock Options, Restricted Stock, Restricted Stock Units, Stock Appreciation Rights, Performance Units and Performance Shares.

Under the 2023 Plan, stock options are to be granted at a price that is not less than 100% of the fair value of the underlying common stock at the date of grant. Awards for employee vest 25% on the first anniversary of the date of grant and ratably each month over the ensuing 36-month period. Awards for independent board members vest ratably each quarter over the ensuing 4-quarter period. The maximum term for stock options granted under the 2023 Plan might not exceed ten years from the date of grant.

Upon original approval, the Company reserved 1,200,000 shares of the Company’s Class A common stock for issuance under the 2023 Plan, no equity incentives have been issued as of September 30, 2023, under the 2023 Plan.